Wound Care CPT Coding in 2026: A Practical Framework for Depth, Documentation, and the New Skin Substitute Payment Rules
Updated: Sep 18

Executive Summary
Wound care coding accuracy depends on one distinction more than any other: which tissue was actually excised, not which tissue was visible in the wound bed. Surgical debridement codes 11042 through 11047 are selected by the deepest tissue the documentation shows was removed — subcutaneous, muscle/fascia, or bone. Active wound care management codes 97597 and 97598 describe a different technique entirely: selective debridement of skin and subcutaneous tissue without excision into deeper structures. Billing the wrong family for the technique actually performed is the single most common source of wound care claim denials our billing specialists see.
2026 also brought a genuinely significant policy change: CMS finalized a new payment methodology for skin substitute products in the CY 2026 Physician Fee Schedule Final Rule, reclassifying most products as incident-to supplies rather than separately payable biologicals and replacing product-specific pricing with a flat, standardized rate. Practices billing skin substitute application codes (15271–15278) should verify their current billing workflow reflects this change rather than the prior payment structure.
MOST IMPORTANT TAKEAWAY Code From What Was Removed, Not What Was Visible • The recurring theme across CMS guidance on debridement coding: depth selection is based on the deepest tissue actually excised into viable, bleeding tissue — not the deepest tissue exposed or visible in the wound. A note describing 'debridement to muscle' without stating that muscle was excised supports a lower-level code than the documentation might seem to imply at first read. |
1. The Wound Care Code Families
Wound care billing spans several distinct code families, each governed by different selection logic. Confusing which family applies to the service performed is where most coding errors originate.
Code Family | CPT Range | What It Describes | Key Selection Logic |
Active wound care management | 97597, 97598 | Selective debridement using scalpel, scissors, curette, or forceps to remove devitalized tissue while preserving viable tissue | 97598 is the add-on for each additional area beyond the first |
Surgical debridement | 11042, 11045, 11043, 11046, 11044, 11047 | Excisional removal of devitalized tissue by depth — subcutaneous, muscle/fascia, or bone | Selected by the deepest tissue actually excised, not the deepest tissue visible |
Non-selective debridement | 97602 | Wet-to-dry dressings, enzymatic debridement, or similar non-selective methods | Separately payable status varies by setting — verify current status indicator |
Negative pressure wound therapy | 97605, 97606, 97607, 97608 | Application and management of NPWT, split by wound size and disposable versus durable equipment | Confirm which code applies based on equipment type and wound surface area |
Skin substitute application | 15271, 15272, 15273, 15274, 15275, 15276, 15277, 15278 | Application of cellular and tissue-based products, split by anatomic site and wound size | Product HCPCS coding and payment methodology changed significantly for 2026 |
Compression therapy | 29580, 29581 | Application of compression systems, typically for venous insufficiency and lymphedema management | Frequently bundled with same-session debridement on the same limb — verify NCCI edits |
A technically valid CPT code from the wrong family does not become correct because it exists — it has to match the technique the provider actually used and documented.
2. The Central Decision: Selective vs. Surgical Debridement
This is the distinction that drives the largest share of wound care denials. Selective active wound care management (97597/97598) and surgical debridement (11042–11047) describe different clinical techniques, and CMS guidance treats them as generally mutually exclusive for the same wound on the same date.
Question | If Yes... | Next Step |
Was tissue actively selected and removed with an instrument (scalpel, curette, scissors, forceps)? | Yes → selective technique | Proceed to the active wound care management or surgical debridement decision below |
Was the deepest tissue removed excised into viable, bleeding tissue? | Yes → surgical debridement (11042–11047), coded by deepest tissue actually excised | Document the specific tissue layer explicitly |
Was the procedure selective debridement of skin/subcutaneous tissue without excision into deeper structures? | Yes → 97597 (first 20 sq cm), 97598 (each additional 20 sq cm) | Document wound measurements before and after |
Was the method non-selective — wet-to-dry dressing, enzymatic, or similar? | Yes → 97602, subject to setting-specific payable status | Verify current status indicator for the billing setting |
Was a skin substitute applied during a covered application procedure? | Yes → 15271–15278 based on site and size, plus applicable product HCPCS | Confirm FDA regulatory category matches the HCPCS code billed |
COMMON MISTAKE Coding From What the Wound Looks Like, Not What Was Done • Why it happens: A wound bed that appears to expose muscle or bone creates a visual impression of depth that documentation doesn't always confirm. • Why it matters: CMS guidance is explicit that depth-based codes reflect tissue actually excised, not tissue visible or exposed. • Better approach: Require an explicit excision statement — the specific tissue layer removed — before selecting a depth-based code. | ||
3. Depth-Based Surgical Debridement: 11042–11047
Surgical debridement is coded according to the deepest tissue layer the provider actually excised — documented as excision into viable, bleeding tissue, not simply reached or exposed.
Code Pair | Tissue Layer | What Must Be True | Documentation That Supports It | Common Gap |
11042 / 11045 | Subcutaneous tissue | Fat and subcutaneous layer excised, no deeper structures involved | Excision documented into viable, bleeding subcutaneous tissue | Depth not explicitly stated |
11043 / 11046 | Muscle and/or fascia | Debridement extends into and includes muscle or fascial tissue | Muscle or fascia explicitly documented as excised | Documenting exposure without excision |
11044 / 11047 | Bone | Debridement extends into and includes bone | Bone tissue explicitly documented as removed, not merely visible | Confusing exposed bone with debrided bone |
EXPERT INSIGHT Exposure Is Not Excision • A wound bed can expose bone without bone ever being debrided. Our coding specialists look specifically for a documented excision statement — that bone tissue was removed — before supporting an 11044 or 11047 code. A note stating only that 'bone was visible in the wound bed' supports a lower code family regardless of how the wound appears clinically. | ||||
If subcutaneous tissue is excised across a total area larger than the first threshold, the additional area is reported using the corresponding add-on code for that depth tier, not by repeating the base code. Add-on codes require the base code from the same depth tier to be reported first.
4. Active Wound Care Management: 97597 and 97598
These codes describe selective debridement of skin and subcutaneous tissue using an instrument-based technique — scalpel, scissors, curette, or forceps — while preserving viable tissue, without excision into deeper structures. CPT 97598 is the add-on code for each additional area beyond the first, and total surface area is generally summed across all wounds treated in the same session when applicable.
The clinical distinction from non-selective debridement (97602) is technique, not outcome. If the provider actively chose which tissue to remove using an instrument, that is selective technique. Non-selective methods — wet-to-dry dressings, enzymatic agents, or similar — are coded differently, and the payable status of 97602 can vary by place of service. Verify the current status indicator for your specific setting before billing it.
5. Skin Substitute Coding: What Changed for 2026
This is the most consequential wound care billing change of the year. According to CMS's own announcement of the CY 2026 Physician Fee Schedule Final Rule, CMS reclassified most skin substitute products from separately payable biologicals to incident-to supplies, moving away from the prior average-sales-price-based model. CMS stated this change is expected to reduce Medicare spending on these products substantially without reducing patient access to appropriate care.
VERIFIED CMS POLICY CHANGE Skin Substitute Payment Restructuring, Effective January 1, 2026 • Source: CMS CY 2026 Medicare Physician Fee Schedule Final Rule (CMS.gov) • Most skin substitute products are now paid as incident-to supplies rather than separately payable biologicals • Payment for most products moved to a standardized national rate rather than product-specific, average-sales-price-based pricing • Products licensed as biologicals under a full Biologics License Application may continue to follow different payment rules — verify current product-specific classification • Practices should confirm the current HCPCS code and FDA regulatory category for each specific product before billing |
Because this policy is new for 2026 and CMS has indicated it may further differentiate payment by regulatory category in future years, treat any specific per-square-centimeter dollar figure you encounter as something to verify directly against the current CMS Physician Fee Schedule Look-Up Tool rather than a fixed number. Coverage criteria and Local Coverage Determination status for skin substitutes have also been an area of active change — verify current MAC-specific coverage policy before assuming a product is covered.
Application procedure codes 15271 through 15278 are selected based on anatomic site and wound surface area. The application code and the product HCPCS code are reported separately, and the code selected must correspond to the actual documented wound location — a code for one anatomic region billed for a wound in a different region is a documentation-to-code mismatch, not a minor technicality.
6. Negative Pressure Wound Therapy (97605–97608)
NPWT coding splits along two variables: total wound surface area and whether disposable, non-durable medical equipment or a durable NPWT pump was used. Selecting the wrong pairing — for instance, using the durable-equipment code when a disposable system was actually applied — is a common, avoidable error. Confirm current code descriptors and equipment-type definitions before billing, since equipment categorization in this space has evolved.
7. Compression Therapy and Same-Session Bundling
Compression bandaging codes 29580 and 29581 frequently accompany debridement in venous ulcer management, but National Correct Coding Initiative edits can bundle compression therapy with surgical debridement when both are performed on the same anatomic site on the same date. Review current NCCI edit pairs before billing both, and don't assume last year's edit status is unchanged this year.
For venous leg ulcers specifically, documentation supporting compression therapy often needs to reflect the vascular assessment — such as an ankle-brachial index or equivalent evaluation — that justifies compression as clinically appropriate rather than contraindicated.
8. The Documentation Elements Every Wound Care Note Needs
☐ Wound location, laterality, and specific anatomic site
☐ Wound length, width, and depth in centimeters, before and after the procedure
☐ Type of tissue present and removed (slough, fibrin, eschar, necrotic tissue, granulation)
☐ Instrument or technique used (scalpel, curette, scissors, forceps, enzymatic agent, etc.)
☐ Explicit statement of the deepest tissue layer excised, for surgical debridement
☐ Confirmation that excision reached viable, bleeding tissue, where applicable
☐ Total surface area treated, summed across wounds where the code requires it
☐ Medical necessity — the clinical reason the procedure was performed
☐ For skin substitutes: product name, HCPCS code, FDA regulatory category, and amount actually applied versus discarded
☐ For compression: vascular assessment supporting appropriateness
☐ Distinct E/M documentation, separate from the procedure note, when modifier 25 is used
A note that would require a coder to guess or infer the depth, technique, or measurements is not ready to support a claim — regardless of how routine the encounter felt clinically.
9. Common Wound Care Billing Errors
Error | Why It Happens | Prevention |
Selecting depth from visible tissue rather than tissue removed | Wound appears to expose muscle, but only subcutaneous tissue was actually excised | Code from what was excised and documented, not what was visible in the wound bed |
Billing 97597 and 11042 on the same wound, same date | These represent different techniques (selective active management vs. surgical excision) and are generally mutually exclusive for the same wound on the same day | Select the code matching the technique actually performed; verify current NCCI edits before billing both |
Missing wound measurements | Add-on codes (97598, 11045–11047) and skin substitute codes are size-based | Document length, width, and depth in centimeters at every encounter |
Using modifier 25 without distinct E/M documentation | The procedure note alone does not justify a separate E/M charge | E/M work must be documented as a distinct clinical narrative, separate from the procedure note |
Skin substitute HCPCS not matching FDA category | Billing a code associated with one regulatory pathway for a product in a different category | Confirm the product's current FDA classification before selecting the HCPCS code |
Non-selective debridement billed in a non-payable setting | 97602 payable status varies by place of service | Verify current status indicator for the specific setting before billing |
Compression therapy billed same-limb, same-day as debridement without modifier review | NCCI edits may bundle compression with surgical debridement on the same anatomic site | Review current NCCI edits before billing both on the same limb, same date |
Diabetic ulcer diagnosis sequencing error | Underlying diabetes diagnosis not sequenced appropriately relative to the ulcer code | Follow current ICD-10-CM sequencing guidance for diabetes with associated ulcer |
Missing ABI documentation for compression therapy | Compression therapy for venous ulcers may require documented arterial status | Confirm and document ABI or equivalent vascular assessment where clinically indicated |
Assuming last year's skin substitute payment rules still apply | 2026 replaced product-specific ASP pricing with a different payment methodology entirely | Verify current-year CMS skin substitute policy before billing |
10. Denial Prevention Matrix
Denial Scenario | Root Cause | Claim Impact | Correction Path | Prevention Control |
Depth not supported | Documentation doesn't explicitly state the tissue layer excised | Billed level exceeds documented depth | Correct to the supported depth and resubmit | Require explicit depth statement in every debridement note |
Mutually exclusive codes billed together | 97597/97598 and 11042–11047 both billed for the same wound, same date | NCCI edit conflict | Determine which technique the documentation actually supports; bill only that code | Pre-submission NCCI edit check for wound care claims |
Missing measurements | No documented wound dimensions to support an add-on code | Add-on code denied or full claim flagged | Correct documentation if possible and resubmit within filing limits | Mandatory measurement fields in the wound care note template |
Skin substitute coding mismatch | HCPCS code doesn't match the product's current FDA category | Denial or payment at an incorrect rate | Verify FDA classification and correct the HCPCS code | Maintain a current product-to-HCPCS crosswalk |
Modifier 25 unsupported | E/M billed alongside a procedure without distinct documentation | E/M denied or bundled | Strengthen documentation going forward; resubmit only if support genuinely exists | Separate E/M and procedure documentation by design |
Non-selective debridement in wrong setting | 97602 billed where its status indicator doesn't support separate payment | Denial specific to place of service | Verify current status indicator; correct POS or code if needed | Setting-specific coding rules built into claim scrubbing |
Medical necessity insufficient | Diagnosis doesn't clearly support the wound care service billed | Denial regardless of coding accuracy | Review documentation-to-diagnosis alignment | Diagnosis selection tied explicitly to the documented wound etiology |
Frequency/MUE exceeded | Units billed exceed the current Medically Unlikely Edit for the code | Excess units denied | Verify current MUE values before submission | Automated unit validation against current MUE data |
11. ICD-10-CM Considerations for Wound Care
Diagnosis coding carries as much weight as procedure coding in wound care claims. A few structural points worth verifying against current ICD-10-CM guidance: pressure ulcer codes require anatomic site, laterality, and stage to be fully specified; diabetic ulcer coding generally requires the underlying diabetes code to be sequenced appropriately relative to the specific ulcer code; and chronic ulcer codes should reflect the documented etiology rather than a generic, unspecified code where a more specific one is supported by the record.
ICD-10-CM updates annually on October 1. Diagnosis selections — particularly around injury and wound-related codes that have seen structural revisions in recent years — should be verified against the current tabular list rather than a saved reference from a prior year.
12. Who Can Bill Wound Care Codes?
Provider Type | General Billing Scope | Payment Considerations | Verification Needed |
Physicians (MD/DO) | All wound care CPT codes within scope of practice | N/A — standard physician fee schedule rate | Confirm current specialty-specific coverage policy |
Nurse practitioners / physician assistants | Wound care codes within state scope of practice | Typically reimbursed at a percentage of the physician rate under Medicare | Verify current NPP payment policy and state scope-of-practice rules |
Physical therapists | 97597 and 97602 under a therapy plan of care, generally not 11042–11047 | Subject to therapy-specific billing rules and modifiers (e.g., GP) | Confirm current therapy modifier requirements |
Occupational therapists | Selected active wound care codes under a therapy plan of care | Subject to therapy-specific modifier requirements (e.g., GO) | Confirm current OT scope for wound care billing |
Podiatrists | Full range of wound care codes within scope, plus routine foot care carve-out considerations | Standard fee schedule, subject to routine foot care exclusions | Verify current routine-foot-care coverage carve-out rules |
Registered nurses | Generally cannot bill independently under Medicare Part B | N/A | Confirm current incident-to or supervision requirements where RN services support billing |
Scope of practice for wound care billing is governed by a combination of state licensure law, payer credentialing, and payer-specific coverage policy. Verify current requirements for each provider type and payer rather than assuming uniform rules across your practice's full payer mix.
13. Wound Care Revenue Integrity Audit
Step | Action | What to Verify |
Step 1 | Pull a sample of recent wound care claims across debridement, NPWT, and skin substitute codes | Sample should span providers and code families |
Step 2 | Compare billed depth against documented tissue excised for each debridement claim | Flag any claim where documentation doesn't explicitly state the depth billed |
Step 3 | Verify wound measurements are present and support any add-on codes billed | Flag claims missing before/after measurements |
Step 4 | For skin substitute claims, confirm HCPCS code matches the product's current FDA category | Flag any mismatch for correction |
Step 5 | Review modifier 25 claims for distinct E/M documentation | Flag procedure-only notes billed with a separate E/M charge |
Step 6 | Check for mutually exclusive code pairs billed on the same wound, same date | Flag 97597/97598 paired with 11042–11047 on the same site and date |
Step 7 | Compare paid amounts against expected reimbursement, especially for skin substitute claims | Flag variance for follow-up |
Step 8 | Summarize findings by pattern — provider, code family, or payer — rather than by individual claim | Convert findings into a specific corrective action |
A structured audit converts a vague sense that "something's off with our wound care claims" into a specific, correctable finding — provider-specific, code-family-specific, or payer-specific — that can actually be fixed rather than repeatedly worked around.
14. Wound Care Billing KPI Dashboard
KPI | What It Measures | Why It Matters |
Depth-coding accuracy rate | Share of debridement claims where billed depth matches documentation on audit | Directly predicts NCCI and audit exposure |
Measurement documentation rate | Share of wound care notes with complete before/after measurements | Missing measurements are a leading cause of add-on code denial |
Skin substitute HCPCS accuracy rate | Share of skin substitute claims matching current FDA category coding | New 2026 payment structure raises the cost of a mismatch |
Modifier 25 support rate | Share of E/M-plus-procedure claims with distinct E/M documentation | A recurring audit target across specialties, not just wound care |
Clean claim rate | Share of wound care claims accepted without correction | Baseline indicator of front-end and coding quality |
Denial rate by code family | Denial rate segmented by debridement, NPWT, skin substitute, and compression | Reveals which code family is driving the practice's denial volume |
Days in A/R (wound care) | Collection speed specific to wound care claims | Wound care often ages differently than general E/M claims |
Underpayment rate | Share of wound care claims paid below the expected or contracted rate | The 2026 skin substitute rate change makes this newly important to monitor |
We have not published target benchmark values for these metrics. Wound care denial and accuracy rates vary considerably by practice setting, payer mix, and patient acuity, and an unverified external benchmark can mislead more than it helps. Establish your own baseline through the audit above, then track direction of travel.
15. Building a 2026 Wound Care Compliance Checklist
Before Billing Any Debridement Claim
☐ Depth of excision explicitly documented, not inferred from wound appearance
☐ Technique (selective vs. surgical vs. non-selective) matches the code family selected
☐ Wound measurements documented before and after the procedure
☐ Mutually exclusive code pairs checked against current NCCI edits
Before Billing Any Skin Substitute Claim
☐ Product's current FDA regulatory category confirmed
☐ HCPCS code matches that category under current CMS policy
☐ Application CPT code matches the documented anatomic site and wound size
☐ Amount of product actually applied versus discarded is documented
☐ Current MAC coverage policy verified for the specific product and indication
Before Billing Any E/M Alongside a Procedure
☐ Distinct E/M documentation exists, separate from the procedure note
☐ Modifier 25 use is supported by that distinct documentation, not just habit
16. When Does Wound Care Billing Complexity Justify Specialized Support?
Wound care billing sits at the intersection of depth-based surgical coding, technique-based active management coding, a newly restructured skin substitute payment system, and diagnosis coding with its own sequencing rules. That combination produces more denial categories than most single-service specialties encounter.
Specialized support tends to be worth evaluating when a practice sees recurring depth-coding denials that internal documentation training hasn't resolved, when skin substitute claims are underpaid or denied at a rate that suggests a systemic HCPCS mismatch, when NCCI edit conflicts recur across the same code pairs, or when the practice lacks the bandwidth to track a payment methodology that changed as significantly as skin substitute billing did for 2026. It is not automatically the right answer for every practice — smaller practices with a narrow wound care scope and strong internal documentation discipline may manage well without outsourced support.
MedCloudMD's Approach to Wound Care Billing
Our certified coding professionals and revenue cycle specialists support wound care providers with documentation review, depth-coding and NCCI edit validation, skin substitute coding aligned to current CMS policy, claim scrubbing, denial management, and revenue-cycle reporting.
We do not promise a specific reduction in denials or guaranteed reimbursement outcomes — no billing partner honestly can, particularly in a code family that just underwent this significant a payment restructuring. What we focus on is helping practices build a documentation and coding workflow that stays aligned with current CMS requirements as they continue to evolve.
Frequently Asked Questions
What is the difference between CPT 97597 and CPT 11042?
CPT 97597 describes selective debridement of skin and subcutaneous tissue using an instrument-based technique, without excision into deeper structures. CPT 11042 describes surgical debridement that excises into subcutaneous tissue as the deepest layer removed. They represent different techniques and are generally not billed together for the same wound on the same date.
How is the depth for surgical debridement (11042–11047) determined?
By the deepest tissue layer the documentation shows was actually excised into viable, bleeding tissue — not the deepest tissue visible or exposed in the wound bed. The operative or procedure note should explicitly state which tissue layer was removed.
What changed with skin substitute billing in 2026?
CMS finalized a new payment methodology in the CY 2026 Physician Fee Schedule Final Rule, reclassifying most skin substitute products as incident-to supplies rather than separately payable biologicals and replacing the prior product-specific, average-sales-price-based payment model with a standardized approach. Practices should verify current rates and coverage policy directly through CMS rather than relying on prior-year figures.
Can 97597 and 11042 be billed together for the same wound?
Generally no, for the same wound on the same date — CMS guidance and NCCI edits treat these as representing different techniques that are typically mutually exclusive when applied to the same wound. Verify current NCCI edit status before billing both.
What documentation supports a skin substitute claim?
The product name, its current FDA regulatory category, the HCPCS code matching that category, the application CPT code matching the documented anatomic site and wound size, and the amount of product actually applied to the patient versus discarded.
Why do wound care claims commonly get denied?
Frequent causes include billing a depth the documentation doesn't explicitly support, pairing mutually exclusive debridement codes on the same wound and date, missing wound measurements for size-based add-on codes, skin substitute HCPCS codes that don't match the product's FDA category, and modifier 25 use without distinct E/M documentation.
Who can bill wound care CPT codes?
Physicians can generally bill the full range of wound care codes within scope. Nurse practitioners, physician assistants, physical therapists, occupational therapists, and podiatrists each have defined billing scope that varies by code family, state law, and payer policy — verify current scope-of-practice and payer credentialing rules for each provider type.
How often should a practice audit its wound care coding?
A structured sample audit on a regular cadence — many practices find quarterly review sufficient, with more frequent review following a significant policy change like the 2026 skin substitute restructuring — helps catch systemic depth-coding or HCPCS-matching errors before they compound across many claims.
Does non-selective debridement (97602) get paid the same as selective debridement?
No, and its payable status can vary by place of service under current CMS payment status indicators. Verify current status for your specific setting before billing, rather than assuming it mirrors selective debridement's payment structure.
What should a wound care practice do to prepare for continued 2026 policy changes?
Verify current CMS guidance directly rather than relying on prior-year references, confirm skin substitute product classifications against current FDA and CMS categories, review NCCI edits periodically rather than assuming they're static, and build documentation habits — explicit depth statements, complete measurements — that hold up regardless of which specific payment methodology is in effect that year.
Sources & References
This guide references the CMS CY 2026 Medicare Physician Fee Schedule Final Rule and CMS's public announcement of the skin substitute payment restructuring (CMS.gov), along with CMS Correct Coding Initiative guidance on debridement code selection by depth and the general coding relationships between active wound care management, surgical debridement, negative pressure wound therapy, and skin substitute application code families. CPT codes and descriptors referenced are summarized rather than reproduced and are copyrighted by the American Medical Association. Coverage policy for skin substitutes and other wound care services has been an area of active revision — verify current Local Coverage Determination status with your specific Medicare Administrative Contractor before billing.
Last reviewed: September 2026
Medicare payment policy, coverage determinations, and CPT/HCPCS coding requirements for wound care continue to evolve. Verify current requirements before submitting claims.
Disclaimer
This article is provided for general educational and informational purposes only and does not constitute legal, medical, coding, billing, or reimbursement advice. Wound care coding requirements, coverage policy, payment methodology, and payer-specific rules can change and may vary by payer, plan, jurisdiction, provider type, and individual patient circumstances. Practices should verify current requirements directly with CMS, applicable Medicare Administrative Contractors, and each relevant payer before submitting claims. MedCloudMD does not guarantee reimbursement, claim approval, or specific financial outcomes.




Comments